Medical device developer Medtronic has received U.S. Food and Drug Administration clearance for its AneuRx AAAdvantage abdominal aortic aneurysm (AAA) stent graft with Xcelerant delivery system.
The system features a low profile and a wider range of lengths, diameters, and other enhancements that allow broader patient applicability than prior Medtronic devices, according to the Minneapolis-based firm.
Enhancements include potentially broader proximal and distal sealing areas due to longer aortic bodies, longer and larger straight iliac limbs, and flared iliac limbs and extensions, Medtronic said. The system also includes improved radiopaque markers and contoured stents, according to the company.
By AuntMinnie.com staff writers
March 28, 2006
Related Reading
SonoSite signs Medtronic Navigation distribution deal, December 8, 2005
Medtronic submits PMA module for Endeavor, October 10, 2005
Medtronic signs O-arm distribution deal, September 29, 2005
Medtronic launches Valiant thoracic stent, July 13, 2005
Medtronic, Cleveland Clinic launch PIVOTAL trial, July 7, 2005
Copyright © 2006 AuntMinnie.com
